findmyKOL

Tamar Polonsky

Basic profile

University of Illinois Chicago

ORCIDNPI
RegionChicago, IL · MidwestSpecialtyCardiovascular DiseaseFocusCardiology
Last active 2023findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding2023–2023Why? →

Tamar Polonsky is a Cardiology physician affiliated with University of Illinois Chicago. OpenAlex indexes 188 publications with 7,572 citations (h-index 38).

Overview

Scholarship

indexed output and impact (OpenAlex)
188publications

Distinct works indexed by OpenAlex, matched via ORCID.

7,572citations

Total citations across indexed works.

38h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 2023–2023

Federally funded research awards.

View funding

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    87.1%
    Beta blocker20.2%
    Metoprolol Succinate51%Carvedilol39%Bisoprolol Fumarate6%Metoprolol Tartrate5%
    Part D<11 patients
    Statin18.1%
    Rosuvastatin Calcium52%Atorvastatin Calcium49%
    Part D105 patients

    + 13 more classes in this area

  • Blood & clotting

    8.5%
    Factor Xa inhibitor6%
    Eliquis66%Xarelto34%
    Part D37 patients
    P2Y12 inhibitor1.8%
    Clopidogrel100%
    Part D19 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    4.4%
    SGLT2 inhibitor3.6%
    Jardiance55%Farxiga45%
    Part D23 patients
    GLP-1 receptor agonist0.4%
    Ozempic100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)90.3% facility · 9.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20232023 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”